Cy-Fair Animal Hospital Leads the Way in Canine Osteoarthritis Pain Management with Librela
Cypress, TX– October 9, 2023 – Cy-Fair Animal Hospital is now offering the industry’s first and only monthly injectable monoclonal antibody therapy designed specifically for dogs suffering from osteoarthritis (OA) pain, Librela. Osteoarthritis is a prevalent and distressing condition for dogs, causing chronic pain and severely affecting their movement and quality of life. Symptoms of osteoarthritis in dogs may include limping, trouble climbing, running, or any drastic changes in mobility. Some dogs may have a genetic condition or be born with hip or elbow dysplasia. This diagnosis may also be more prevalent in dogs who are overweight.
Pet parents can help prevent or reduce the impact of osteoarthritis by feeding their dogs a healthy diet and getting them lots of exercise. For pets living with OA pain, Librela offers a groundbreaking solution that controls OA pain, leading to increased activity and improved quality of life.
Librela’s standout feature lies in its strength as a blocker of canine nerve growth factor (NGF) activity, the cause of OA pain. “When dogs have hip, knee, shoulder, elbow, or any joint pain, nerves feel it,” said Dr. Diarra Blue, Co-Owner and Veterinarian at Cy-Fair Animal Hospital. “Nerve growth factor can stimulate a cascade, which leads to perception of pain in the brain. How Librela works is it is a monoclonal antibody that binds to where that factor would be, and it says, no longer will you be stimulated.” By blocking NGF activity, Librela offers a practical approach to reducing pain, making it a significant advancement in veterinary medicine.
Cy-Fair Animal Hospital is one of the pioneering hospitals to offer Librela. “We see about 40% of animals, if not more, dogs and cats that have osteoarthritis as they develop,” said Dr. Blue. “Most animals on oral medication for osteoarthritis probably only receive two to three months of medication throughout the year, so they’re not even getting the medication’s benefit the entire time; they’re getting it part-time.”
Key benefits of Librela include:
- Effective control of canine OA pain with a monthly injection.
- Increased activity and improved quality of life.
- Monthly injectable therapy.
- No damage to the kidneys or liver
Cy-Fair Animal Hospital encourages dog owners to be proactive in the prevention of osteoarthritis. If your pet is showing signs and symptoms of this condition, please seek veterinary care.
About Cy-Fair Animal Hospital
Cy-Fair Animal Hospital is a renowned full-service animal hospital and boarding facility. Their dedication to modern veterinarian techniques is matched only by their love for animals and healthcare. With a commitment to excellence, they serve communities in Houston, Texas, Addison, Dallas/Fort Worth, and surrounding areas.
Learn more about Cy-Fair Animal Hospital at www.cyfairanimalhospital.com
Media Contact:
Kulur Group
LeeAnah James
ljames@kulurgroup.com
About Librela
Librela is the first and only monthly injectable monoclonal antibody therapy designed exclusively for dogs suffering from osteoarthritis (OA) pain. By targeting canine nerve growth factor (NGF) activity, Librela offers a groundbreaking solution for effectively managing OA pain, leading to increased activity and improved quality of life for dogs.
